Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Off Label Use of Dapsone in SARS-CoV-2 Hospitalized Patients

NCT04918914 is registered in ClinicalTrials.gov with Hunt Regional Medical Center as lead sponsor.

NCT NCT04918914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Off Label Use of Dapsone in SARS-CoV-2 Hospitalized Patients
Lead sponsor
Hunt Regional Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
October 18, 2020
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, hypoxia, sars-cov-2